Literature DB >> 16901802

Secondary osteoporosis: a review of the recent evidence.

Stephanie E Painter1, Michael Kleerekoper, Pauline M Camacho.   

Abstract

OBJECTIVE: To review several causes of secondary osteoporosis as well as screening recommendations for underlying disorders.
METHODS: We conducted a review of the literature on many of the causes of osteoporosis that have been published during the past 15 years, focusing on those sources available from 2000 through the present. Indeed, more than two-thirds of the articles that we reviewed were printed during the past 6 years. These reports examined secondary osteoporosis in general, as well as many of the specific causes.
RESULTS: Secondary osteoporosis occurs in almost two-thirds of men, more than half of premenopausal and perimenopausal women, and about one-fifth of postmenopausal women. Its causes are vast, and they include hypogonadism, medications, hyperthyroidism, vitamin D deficiency, primary hyperparathyroidism, solid organ transplantation, gastrointestinal diseases, hematologic diseases, Cushing's syndrome, and idiopathic hypercalciuria. These causes have their own pathogenesis, epidemiologic features, and effect on the skeleton.
CONCLUSION: The causes of secondary osteoporosis are numerous, and an understanding of their characteristics with respect to bone density and potential fracture risk is essential in the management of osteoporosis. A heightened awareness of the possibility of their existence is necessary to provide optimal care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901802     DOI: 10.4158/EP.12.4.436

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  33 in total

1.  The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis.

Authors:  F E McKiernan; R L Berg; J G Linneman
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

2.  Short-term and long-term orthopaedic issues in patients with fragility fractures.

Authors:  Susan V Bukata; Stephen L Kates; Regis J O'Keefe
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

3.  Insufficiency avulsion fracture of the femoral attachment of the posterior cruciate ligament of the knee joint.

Authors:  Omar M Albtoush; Marius Horger
Journal:  Skeletal Radiol       Date:  2017-04-26       Impact factor: 2.199

Review 4.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

5.  A guide to improving the care of patients with fragility fractures.

Authors:  Susan V Bukata; Benedict F Digiovanni; Susan M Friedman; Harry Hoyen; Amy Kates; Stephen L Kates; Simon C Mears; Daniel A Mendelson; Fernando H Serna; Frederick E Sieber; Wakenda K Tyler
Journal:  Geriatr Orthop Surg Rehabil       Date:  2011-01

6.  The value of hypercalciuria in patients with osteopenia versus osteoporosis.

Authors:  María Sierra Girón-Prieto; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Salvador Arias-Santiago; Tomás de Haro-Muñoz; Miguel Arrabal-Martín; Miguel Ángel Arrabal-Polo
Journal:  Urolithiasis       Date:  2016-08-01       Impact factor: 3.436

Review 7.  The Potential of Probiotics as a Therapy for Osteoporosis.

Authors:  Fraser L Collins; Naiomy D Rios-Arce; Jonathan D Schepper; Narayanan Parameswaran; Laura R McCabe
Journal:  Microbiol Spectr       Date:  2017-08

8.  A tuber calcanei avulsion fracture developed on the basis of idiopathic osteoporosis in a young male: a case report.

Authors:  R Terzi; T Özer
Journal:  Osteoporos Int       Date:  2015-04-08       Impact factor: 4.507

Review 9.  Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?

Authors:  Stuart J Warden; Robyn K Fuchs
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

10.  Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.

Authors:  Mir Sadat-Ali; Abdulmohsen H Alelq; Badar A Alshafei; Haifa A Al-Turki; Mohammed A Abujubara
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.